Safety and Immunogenicity of Sanaria's Irradiated Sporozoite Vaccine (PfSPZ Vaccine) in Malaria-Experienced Adults in Burkina Faso

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This study is a phase 1, randomized, double-blind, placebo-controlled, dose escalation trial of Sanaria\'s irradiated sporozoite vaccine (PfSPZ vaccine). The primary objective of this protocol is to determine the safety and reactogenicity of the PfSPZ Vaccine in malaria-experienced healthy adults. The study duration shall be 34 months and subject participation duration shall be 15-26 months.
Epistemonikos ID: 4404703759fdcb446348303ddb72199918d62e38
First added on: May 12, 2024